A rare disease is any disease that affects a small percentage of the population and are frequently debilitating to patients. Timely access to the right treatment is crucial for effective disease management and delayed access contributes to poorer treatment outcomes and more severe disease complications. This policy paper “Improving access to orphan drugs in Malaysia” explores the challenges associated with accessing orphan drugs in Malaysia and proposes ways in which we can improve patient access to these drugs.
Read more at Institute for Democracy and Economic Affairs (IDEAS)